BIOGEN INC (BIIB) - Price, trends, fundamentals and chart - Passport to Wall Street

BIOGEN INC (NASDAQ: BIIB)

Overview

current price

$150.64

$150.64

change

0.15 | 0.10%

0.15 | 0.10%

Yesterday's Close

150.49

open

150.16

volume

1.38 M

30d. avg volume.

1.62 M

1 day

149.93 - 154.24

52 weeks

148.60 - 268.30

p/e

13.61

beta

-0.0807

market cap

21.93 B

dividend yield

0.00%

Industry

-

News and Commentary

Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibod... On Tuesday, the FDA approved Eli Lilly and Co's (

Rising Stars, Falling Trends: July's Industry ETF Winners and Losers As July comes to an end, it's time to take a look at the best- and worst-performing industry ETFs for the month.Among the largest ETFs that represent ma...

Market Update: Dow Rallies 700 Points on Hopes Inflation is Easing Stocks staged their first rally of 2023 to close out the week higher on Friday after the December jobs report and other economic data showed signs that inflation may be cooling....

Biogen’s Alzheimer Drug Shows Promise in Key Study For the first time, a drug has been shown to

Market Update: Stocks Rebound from 2022 Low, Dow and S&P Snap Six-Day Losing Streak Stocks rose on Wednesday as U.S. Treasury yields retreated from multi-year highs. Benchmarks rebounded off bear market lows, with the Dow Jones Industrial Average jumping over 50...

Medicare to Reassess Premium Hike Meant to Cover Alzheimer Drug Costs Medicare is being asked by U.S. health secretary Xavier Becerra to

Market Update: Benchmarks Hit Record Closing Highs on Comeback Rally Wall Street benchmarks all reached record closing highs on Friday, rebounded from depressed levels in the previous session as market participants shook off concern over global ec...

FDA Grants Approval to Biogen's Alzheimer's Treatment, Met with Controversy Biogen's (BIIB

FDA Approves Controversial Alzheimer's Drug Despite Expert Advice In an unprecedented move, health officials with the Food and Drug Administration (FDA) have approved a new Alzheimer's drug based on results showing only that the drug was "reaso...

Market Update: Stocks Rally Ahead of U.S. Presidential Election Results Stocks rose on Wednesday ahead of the results of the 2020 U.S. presidential election, which so far has no clear winner and ballots may take a few days to count due to unprecedent...

StockTwits

StockTwits

Join now and unlock premium features

Access to premium stock and ETF data including financials, holdings and more
Participate in trading contests and earn real prizes
Sync you favorite articles and symbols between all of your device
And much more